XLRN - Acceleron Pharma Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue13,48127,77118,097
Cost of Revenue---
Gross Profit13,48127,77118,097
Operating Expenses
Research Development89,72668,58058,404
Selling General and Administrative33,73825,29720,572
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-109,983-66,106-60,879
Income from Continuing Operations
Total Other Income/Expenses Net1,5619,116-3,015
Earnings Before Interest and Taxes-108,422-56,990-63,894
Interest Expense---
Income Before Tax-108,422-56,990-63,894
Income Tax Expense3224-
Minority Interest---
Net Income From Continuing Ops-108,454-57,014-63,894
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-108,454-57,014-63,894
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-108,454-57,014-63,894